[HTML][HTML] Leukemia lineage-specific chimerism analysis and molecular monitoring improve outcome of donor lymphocyte infusions
D Sairafi, M Remberger, M Uhlin, P Ljungman… - Biology of Blood and …, 2010 - Elsevier
A retrospective analysis was performed of 118 patients with hematologic malignancies who
received donor lymphocyte infusions (DLIs) after allogeneic stem cell transplantation …
received donor lymphocyte infusions (DLIs) after allogeneic stem cell transplantation …
Leukemia Lineage-Specific Chimerism Analysis and Molecular Monitoring Improve Outcome of Donor Lymphocyte Infusions
D Sairafi, M Remberger, M Uhlin, P Ljungman… - Biology of Blood and …, 2010 - infona.pl
A retrospective analysis was performed of 118 patients with hematologic malignancies who
received donor lymphocyte infusions (DLIs) after allogeneic stem cell transplantation …
received donor lymphocyte infusions (DLIs) after allogeneic stem cell transplantation …
Leukemia lineage-specific chimerism analysis and molecular monitoring improve outcome of donor lymphocyte infusions.
D Sairafi, M Remberger, M Uhlin… - Biology of Blood and …, 2010 - europepmc.org
A retrospective analysis was performed of 118 patients with hematologic malignancies who
received donor lymphocyte infusions (DLIs) after allogeneic stem cell transplantation …
received donor lymphocyte infusions (DLIs) after allogeneic stem cell transplantation …
[PDF][PDF] Leukemia Lineage-Specific Chimerism Analysis and Molecular Monitoring Improve Outcome of Donor Lymphocyte Infusions
D Sairafi, M Remberger, M Uhlin… - Biol Blood Marrow …, 2010 - cyberleninka.org
Allogeneic stem cell transplantation (ACST) can be curative and give long-term survival in a
high proportion of patients with hematologic malignancies and nonmalignant disorders of …
high proportion of patients with hematologic malignancies and nonmalignant disorders of …
[HTML][HTML] Leukemia Lineage-Specific Chimerism Analysis and Molecular Monitoring Improve Outcome of Donor Lymphocyte Infusions
D Sairafi, M Remberger, M Uhlin… - Biology of Blood and …, 2010 - tctjournal.org
A retrospective analysis was performed of 118 patients with hematologic malignancies who
received donor lymphocyte infusions (DLIs) after allogeneic stem cell transplantation …
received donor lymphocyte infusions (DLIs) after allogeneic stem cell transplantation …
[HTML][HTML] Leukemia Lineage-Specific Chimerism Analysis and Molecular Monitoring Improve Outcome of Donor Lymphocyte Infusions
D Sairafi, M Remberger, M Uhlin… - Biology of Blood and …, 2010 - astctjournal.org
A retrospective analysis was performed of 118 patients with hematologic malignancies who
received donor lymphocyte infusions (DLIs) after allogeneic stem cell transplantation …
received donor lymphocyte infusions (DLIs) after allogeneic stem cell transplantation …
[PDF][PDF] Leukemia Lineage-Specific Chimerism Analysis and Molecular Monitoring Improve Outcome of Donor Lymphocyte Infusions
D Sairafi, M Remberger, M Uhlin, P Ljungman… - Biol Blood Marrow …, 2010 - core.ac.uk
Allogeneic stem cell transplantation (ACST) can be curative and give long-term survival in a
high proportion of patients with hematologic malignancies and nonmalignant disorders of …
high proportion of patients with hematologic malignancies and nonmalignant disorders of …
Leukemia lineage-specific chimerism analysis and molecular monitoring improve outcome of donor lymphocyte infusions
D Sairafi, M Remberger, M Uhlin… - Biology of blood …, 2010 - pubmed.ncbi.nlm.nih.gov
A retrospective analysis was performed of 118 patients with hematologic malignancies who
received donor lymphocyte infusions (DLIs) after allogeneic stem cell transplantation …
received donor lymphocyte infusions (DLIs) after allogeneic stem cell transplantation …
[PDF][PDF] Leukemia Lineage-Specific Chimerism Analysis and Molecular Monitoring Improve Outcome of Donor Lymphocyte Infusions
D Sairafi, M Remberger, M Uhlin… - Biol Blood Marrow …, 2010 - researchgate.net
Allogeneic stem cell transplantation (ACST) can be curative and give long-term survival in a
high proportion of patients with hematologic malignancies and nonmalignant disorders of …
high proportion of patients with hematologic malignancies and nonmalignant disorders of …